Overview
Since its 2024 launch, the MSK Therapeutics Accelerator has supported 10+ collaborations with promising preclinical- and clinical stage-companies.
The MSK Therapeutics Accelerator’s Cohort Program provides a structured runway for companies and MSK faculty to explore and define new collaborations.
The Cohort Program holds an annual application round during which interested companies can submit proposals for collaborating with MSK. Applications are evaluated with consideration for the potential impact of the therapeutic program, the company’s health and record, as well as the feasibility of co-development at MSK.
Selected companies are matched with MSK faculty according to their scientific and clinical needs. These companies benefit from one-on-one mentorship with a faculty sponsor and structured introductions to MSK’s translational and clinical facilities. Cohort programming also includes pitch development, media coaching, and in-person pitch showcases to broadcast companies to the broader MSK research community and key external stakeholders.
For questions about the MSK Therapeutics Accelerator or to apply, reach out to Jonathan Dow, PhD, Senior Program Manager, at dowj@mskcc.org.